FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma

PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with unresectable malignant pleural […]

Lower back pain: The natural supplement that may alleviate your symptoms

Lower back pain can be divided into categories – non-specific and specific. The former is the far more common type of back pain, according to Bupa. It describes back pain that cannot be easily attributed to a specific cause, whereas specific back pain can be assigned to a serious condition or damage. Non-specific lower back […]

Cancer centers to address pandemic’s impact on cancer prevention, treatment

A consortium of 17 U.S. cancer centers – including Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine – have come together to better understand the consequences of the COVID-19 pandemic in delaying cancer detection, care and prevention. The cancer centers are working together with the National Cancer Institute on the impact […]

A new treatment concept for age-related decline in motor function

In an aging society, one of the most important and urgent tasks of scientific research is to counteract the decline in motor function and muscle weakness that accompanies the aging process. A research group led by Professor Yuji Yamanashi of the Institute of Medical Science, the University of Tokyo, conducted experiments using aged mice to […]

Researchers develop promising new treatment of advanced skin cancer

A new type of immunotherapy for the skin cancer malignant melanoma shows promising results. Three severely ill patients are now long-term survivors. The study, published in OncoImmunology, is the result of a collaboration between researchers at Karolinska Institutet and Karolinska University Hospital. “Immunotherapy is based on activation of the body’s own immune defense to eliminate […]

US announces clinical trial of antibody treatment for COVID-19

The US has begun late stage clinical trials into a drug formulated to fight COVID-19, officials said Tuesday. The medicine is an antibody against the new coronavirus called LY-CoV555, which was identified in the blood sample of a recovered patient by Canada’s Abcellera Biologics. It was then developed synthetically for mass production by US-based Lilly […]

Scientists leverage interference between signaling pathways for cancer treatment

In order for cancer to form in the human body, normal cells must acquire multiple mutations before they develop toward the disease. It was previously believed that these mutations acted in concert in the progression of cancer. But a new Nature study led by City of Hope’s Markus Müschen, M.D., Ph.D., chair of the Department […]